| 產(chǎn)品名稱 | Apixaban - BMS 562247-01 |
| 產(chǎn)品貨號(hào) | Axon 1754 CAS [503612-47-3] MF C25H25N5O4MW 459.50 Purity: 98% Soluble in DMSO Description Direct factor Xa inhibitor; being investigated as an anticoagulant References Certificates Categories Extra info CB Grange et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N. Engl. J. Med. 2011, 365, 981-992. ? JH Alexander et al. Apixaban with antiplatelet therapy after acute coronary syndrome. N. Engl. J. Med. 2011, 365(8), 699-708. ? SJ Connolly?et al.?Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 2011,?364(9), 806–817. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Factor Xa EC 3.4.21.6 Factor Xa inhibitor Chemical name 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide Parent CAS No. [503612-47-3] Order Size Unit Price Stock 10 mg €125.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Apixaban - BMS 562247-01Axon 1754 CAS [503612-47-3] MF C25H25N5O4
Description
Direct factor Xa inhibitor; being investigated as an anticoagulant
Factor Xa inhibitor
Chemical name1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide Parent CAS No.[503612-47-3] |
| 產(chǎn)品資料 |
